Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRC | Q99895 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.46 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.46 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.45 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.43 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26552001 | 0.89 | MEN1 (0.50) | CTRCALDH1A1HPGDCYP3A4CYP11B2 | |
| SCHEMBL26567326 | 0.88 | CYP1A2 (0.49) | CYP1A2ALDH1A1CYP2C9HPGDSMN1; SMN2 | |
| SCHEMBL31145084 | 0.87 | CCR1 (0.52) | CTRCCYP1A2ALDH1A1CYP2C9HPGD | |
| SCHEMBL26564732 | 0.87 | CYP11B1 (0.56) | CYP1A2ALDH1A1CYP2C9HPGDSMN1; SMN2 | |
| SCHEMBL13134511 | 0.87 | CCR1 (0.52) | CTRCCYP1A2ALDH1A1CYP2C9HPGD | |
| SCHEMBL18325222 | 0.85 | CTRC (0.49) | CTRCCYP1A2ALDH1A1CYP2C9HPGD | |
| SCHEMBL18325357 | 0.85 | CTRC (0.49) | CTRCCYP1A2ALDH1A1CYP2C9HPGD | |
| SCHEMBL26548691 | 0.85 | CYP11B2 (0.44) | CYP1A2ALDH1A1CYP2C9HPGDSMN1; SMN2 | |
| SCHEMBL26567218 | 0.85 | PKM (0.47) | CYP1A2ALDH1A1CYP2C9HPGDSMN1; SMN2 | |
| SCHEMBL26554418 | 0.84 | CYP11B1 (0.46) | CYP1A2ALDH1A1CYP2C9HPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | LAPTO CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | AOC1, ODC1, PIEZO1 | CTRC 2286/4885CYP1A2 670/4885ALDH1A1 77/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.